Patra S, Karthik K (2020) Noonan Syndrome – A Perceptive. Ann Breast Cancer Res 4(1): 1016.

Noonan syndrome (NS) is a hereditary issue that may give somewhat dysmorphology facial highlights, short stature, inherent coronary illness, draining issues, inborn heart defects, and skeletal malformations. The major facial highlights of NS are hypertelorism with down-inclining palpebral crevices, ptosis, and low-set posteriorly turned ears with a thickened helix. The cardiovascular imperfections most generally connected with this condition are pneumonic stenosis and hypertrophic cardiomyopathy. Other related highlights are the webbed neck, chest deformation, mild intellectual deficit, and cryptorchidism, poor feeding in infancy, bleeding propensity, and lymphatic dysplasia. The breast-bone might be either jutting or be depressed, while the spine might be strangely curved. Complications of NS may incorporate leukemia [1].

Various hereditary changes can result in Noonan syndrome. The condition might be acquired from an individual’s parents or happen as a new mutation during early development. It is autosomal dominant (caused by a missense mutation in the PTPN11 quality on chromosome 12). Noonan syndrome is a kind of RASopathy, the underlying mechanism for which includes an issue with a cell-signaling pathway - resulting in an increase of capacity of the non-receptor protein tyrosine phosphatase SHP2 protein. As of late, the mutation in the KRAS quality has been recognized to a limited extent of patients with NS.

The determination might be suspected dependent on side effects by a DNA test for this mutation analysis that can be completed on blood, chorionic villi, and amniotic liquid examples. NS should be considered in all fetuses with polyhydramnios, pleural emissions, edema, and increasing nuchal liquid with a typical karyotype, clinical imaging, and blood test. With uncommon consideration and counseling, most of the children with NS will grow up and function ordinarily in the adult world. The executives should address encouraging issues in early adolescence, evaluation of cardiovascular function, and assessment of development and motor development. Physiotherapy and additionally, speech therapy ought to be offered whenever indicated [2]. A complete eye examination and hearing assessment should be performed during the initial few years of schooling. Preoperative coagulation thinks about are demonstrated. Symptoms and signs are diminished with age, and most adults with NS do not require specialized medical care.

History

Jacqueline Noonan was practicing as a pediatric cardiologist at the University of Iowa when she notices that children with an uncommon sort of heart deformity, valvular pneumonic stenosis, frequently had a characteristic physical appearance, with short stature, webbed neck, wide, divided eyes, and low-set ears. Both young genders were affected. These attributes were now and again observed running in families, yet we are not related to gross chromosomal variations of abnormalities. She considered 833 individuals with Noonan syndrome at the congenital coronary disease clinic, searching for other congenital variations of abnormalities, and in 1963 exhibited a paper: “Related noncardiovascular abnormalities in children with congenital heart disease.” This described nine children who, notwithstanding hereditary coronary disease, had characteristic facial features, chest deformations, and short stature.

Dr. John Opitz, a former student of Dr. Noonan’s, initially started to call the condition “Noonan syndrome” when he saw children who resembled those whom Dr. Noonan had described. Dr. Noonan produced a paper entitled “Hypertelorism with Turner Phenotype” in 1968, and in 1971 at the Symposium of Cardiovascular defects, the name ‘Noonan syndrome’ turned out to be authoritatively recognized [3].

Growth Factor

During childbirth, the average length is 47 cm. Birth weight is general typical (40%) yet can be high, secondary to subcutaneous edema. Prepubertal development tends to parallel the 3rd centile (60%) with a moderately ordinary growth velocity. The pubertal growth spurt is regularly decreased or absent. In cases, up to 20%, delayed bone age was reported. Ordinary development hormone levels with somewhat raised somatomedin levels have been found in some patients. NS patient growth curve for males and females currently available.

Craniofacial

In the infant period, the primary features are hypertelorism with descending inclining palpebral fissures (95%), low set, posteriorly turned ears with a thick helix (90%), profoundly notched philtrum with high, vast pinnacles of the vermilion border of the upper lip (95%), high angled palate (45%), micrognathia (25%), and overabundance nuchal skin with low posterior hairline (55%). Facial appearance changes with age. In early infant stages, the head appears moderately large with turricephaly, conspicuous eyes with level palpebral fissures, hypertelorism, and thick hooded eyelids. The nose is small, upturned, broad base, and bulbous tip. In the child, the face frequently seems coarse or myopathic. The form of the face turns out to be progressively triangular with age. The eyes are less prominent in the adolescent and young adult, and the nose has a pinched root, a more slender, higher connect, and a broad base. The neck stretches, emphasizing the webbing or prominent trapezius (90%). In the older adult, there are prominent nasolabial folds, a high anterior hairline, and transparent, wrinkled skin. Hair may be wispy in the little child, though it is frequently curly or wooly in the older child and adolescent. Features that are regularly present regardless of age are strikingly blue or blue-green irides, diamond shape, arched eyebrows, and low set, posteriorly turned ears with a thick helix.

Ectoderm

Different skin manifestation includes patches (10%), lentigines (2%), pigmented naevi (25%), and keratosis pilaris atrophicans facies (5 cases). A few patients with neurofibromatosis besides, the Noonan phenotype are recorded, incorporating one with hyperplasia of the myenteric intestinal plexus.

Genitourinary

In the male, the case of pubertal improvement changes from normal virilization and ensuing fertility to delayed average adolescence or too lacking auxiliary sexual advancement related to inadequate spermatogenesis discretionary to earlier cryptorchidism (60%). The last cases have raised gonadotrophin levels. A large portion of females is fertile. Pubescence may be regular or delayed. As a rule, gonadotrophin levels are typical.

Cardiovascular

Congenital heart defects are found in 85% of patients. Fundamental anomalies include pneumonic valvular stenosis (50%), atrial septal defect (10%), asymmetrical septal hypertrophy (10%), ventricular septal defect (5%), constant ductus arteriosus (3%), and hypertrophic cardiomyopathy. Pulmonary artery branch stenosis, mitral valve prolapses, Ebstein’s anomaly, and single ventricles have additionally been described. The electrocardiograph naturally shows an extensive QRS complex, left axis deviation, giant Q waves, and a negative pattern in the left precordial leads.

Gastrointestinal

Inability to thrive from infancy to puberty (75%), Decreased appetite, Intestinal malrotation, Digestive problems, Frequent or forceful vomiting, Low gut motility, Swallowing difficulties, Need for a feeding tube, and Gastroparesis (delayed gastric emptying)

Lymphatics

Congenital dysplasia, hypoplasia, or aplasia of lymphatic channels (20%), produces general lymphoedema (10 cases), peripheral lymphoedema (6 cases), pneumonic lymphangiectasia (four cases), intestinal lymphangiectasia (3 cases), hydrops fetalis (3 cases), and cystic hygroma (2 cases).

Skeletal

A characteristic pectus disfigurement is seen with a prominence of the breast bone (pectus carinatum) superiorly and depression of breast bone (pectus excavatum) inferiorly (70%). The thorax is broad, taking on an inverted pyramid shape. In childhood, the upper chest seems to extend, with the presence of generally low set areolas and axillary webbing, which continue to adulthood. The shoulders are regularly rounded. Standard features incorporate cubitus valgus (50%), hand irregularities including clinic brachydactyly and blunt fingertips (30%), joint contraction, joint hypermobility, winging of the scapula vertebral (Scoliosis/lordosis)/sternal peculiarities (25%), and dental malocclusion (35%).

Hematology

Draining peculiarities (20%) include factor VIII, XI, XII partial deficiency, von Willebrand’s diseases, Amegakaryocytic thrombocytopenia, prolonged activated thromboplastin time, combined coagulation defects, imbalance of plasminogen activator inhibitor type-1(PAI-1) activity, imbalance of tissue plasminogen activator (t-PA) activity and platelet dysfunction which might be related with trimethylaminuria.

Other Features

Rarely related highlights incorporate immune system thyroiditis (5 cases), Arnold-Chiari malformation with syringomyelia (1 case), pheochromocytoma (1 case), ganglioneuroma (1 case), harmful schwannoma (1 case), inborn contractures (4 cases), skin and oral xanthomas (1 case), intrinsic hypoplastic weakness (1 case), odontogenic keratosis (1 case), malignant hyperthermia (8 cases), polydactyly (1 case), inborn bone marrow hypoplasia (1 case), and vasculitis (2 cases).

Behavior/Development

A conspicuous feature is an inability to thrive in the earliest stages (40%), learning inability with specific visualconstructional problems, motor development delay (26%), and verbal execution discrepancy (15%). Language delay (20%) might be secondary to perceptual-motor disability, mild hearing loss (12%), or explanation abnormalities (72%). The level of intelligence runs somewhere in the range of 64 and 127, with a median of 102, the IQ as 10 points underneath that of unaffected relatives. Moderate mental retardation is seen in up to 35% of cases [4].

Causes & Types

Repeat in siblings and clear transmission from parent to children has since a long time recommended a hereditary defect with autosomal dominant inheritance and variable expression. Mutation in the Ras/mitogen-activated protein kinase signaling pathways are known to be responsible for about 70% of Noonan syndrome cases. People with NS have up to a 50% possibility of transmitting it to their posterity. The way that an affected parent is not always distinguished for children with Noonan syndrome recommends a few several outcomes: Indications could be so subtle as to go unrecognized (variable expressivity).

Noonan syndrome is heterogeneous, involving more than one comparable state of different causes, and some of these may not be acquired. A high proportion of cases may speak to new, sporadic mutations. Female patients with Noonan disorder have typical pubertal improvement and fertility, while fertility in males with undescended testicles might be diminished. Hence, the mother is all the more, much of the time, the transmitting parental in familial cases [2].

There are various types of Noonan syndrome.

Noonan Syndrome Type 1

This type of NS is a significant kind of syndrome among this sort at nearly half of cases. In this, the gene called PTPN11 gene mutated at locus 12q24.1 of the chromosome. This gene encodes the protein tyrosine phosphatase SHP-2. This protein is a part of a few intracellular sign transduction pathways associated with embryonic advancement that modulate cell division, separation, and movement, including one mediated by the epidermal development factor receptor, which is significant in the formation of the semilunar heart valves. Duplication of the chromosome locale containing PTPN11 can likewise bring about Noonan syndrome.

Noonan Syndrome Type 2

NS type 2 is utilized with this section in evidence that autosomal passive Noonan syndrome two is brought about by homozygous or compound heterozygous mutation in the LZTR1 gene on 22q11.21 chromosome.

Noonan Syndrome Type 3

This form of Noonan syndrome is caused by heterozygous mutation in the KRAS gene on the 12p12.1 chromosome.

Noonan Syndrome Type 4

This type of Noonan syndrome is caused by heterozygous mutation in the SOS1 gene on the 2p22 chromosome. For a phenotypic description of this syndrome is genetic heterogeneity of Noonan syndrome type 1. Activating mutations in SOS1 can give rise to Noonan syndrome. SHP-2 and SOS1 positively manage the Ras/MAP kinase pathway, recommending that its dysregulation mediates Noonan syndrome development.

Noonan Syndrome Type 5

Noonan syndrome is caused by heterozygous mutation in the RAF1 gene on 3p25 chromosome. This syndrome is also a phenotypic description with genetic heterogeneity of Noonan syndrome type 1. Molecular Genetics is analyzed by the RAF1 gene, a serine-threonine kinase that activates MEK1 and MEK2 in 231 individuals with Noonan syndrome who did not have mutations in the PTPN11, KRAS, or SOS1 genes.

Noonan Syndrome Type 6

This form of Noonan syndrome is caused by heterozygous mutation in the NRAS gene on the 1p13 chromosome. One proband of four unrelated probands had an affected mother.

Noonan Syndrome Type 7

This form of Noonan syndrome is caused by heterozygous mutation in the BRAF gene on the 7q34 chromosome. It related to Cardiofaciocutaneous syndrome, and LEOPARD syndrome-3 can also be caused by a mutation in the BRAF gene, indicating that they are allelic disorders.

Heterozygous changes in NRAS, HRAS, BRAF, SHOC2, MAP2K1, MAP2K2, and CBL have likewise is related to a smaller level of Noonan syndrome and related phenotypes. A condition is known as “neurofibromatosis-Noonan disorder” is related with neurofibromin.

Diagnosis

Noonan disorder is heterogeneous, however clinically recognizable, numerous inherited anomaly syndrome. Scoring frameworks can help the diagnosis procedure. Noonan syndrome, for the most part, happens on a sporadic basis with autosomal dominant inheritance. The predominance of maternal transmission is observed. The once more PTPN11 mutation in sporadic Noonan syndrome cases is predominantly of paternal origin. In any case, there is evidence for an uncommon autosomal recessive type of Noonan syndrome [5].

Differential Diagnosis

There are various conditions with phenotypes strikingly like Noonan syndrome. The first to specify is Turner syndrome (45, X0), a notable chromosomal variation in girls. At that point, there is a group of distinct syndromes with partially overlapping phenotypes wherein causative changes found in genes of the RASMAPK pathway. These include Cardio-Facio-Cutaneous (CFC) syndrome, Costello syndrome, Neurofibromatosis type 1 (NF1), and LEOPARD syndrome (various lentigines, ECG conduction irregularities, ocular hypertelorism, pulmonic stenosis, abnormal genitalia, retardation of development and deafness). People with LEOPARD syndrome may have particular mutations in PTPN11, which lead to the reduced catalytic activity of these SHP-2 mutants. Costello syndrome is caused by mutations in HRAS, NF1 by mutations in Neurofibromin and CFC syndrome by mutations in BRAF, KRAS, and MEK1/2. The syndrome that is described by facial dysmorphology, short stature, and heart defects may sometimes be difficult to separate from Noonan syndrome, outstandingly Williams syndrome, and Aarskog syndrome.

Ultrasound Diagnosis

The first-trimester ultrasound of Noonan syndrome may uncover nuchal edema or cystic hygroma like Turner syndrome. Follow-up scans may show clinical features as depicted previously. A study shows this disease is likewise connected with hepatosplenomegaly and with kidney irregularities, including malrotation and a solitary kidney. An uncommon case of choledochal cysts is likewise reported.

Antenatal Diagnosis

Noonan syndrome ought to be considered in all fetuses with polyhydramnios, pleural effusions, edema, and increased nuchal fluid with a normal karyotype. On the off chance that there is clinical evidence of Noonan syndrome in the embryo or a first-degree relative has Noonan syndrome, obstetric ultrasound is indicated at 12–14 and 20 weeks’ incubation and again in the third trimester. Fetal echocardiography is shown at 18–20 weeks’ development. On the off chance that NS is suspected in the unborn child, physical assessment of the parents for features of the syndrome is shown. As standardization of the facial phenotype with age is typical in Noonan syndrome, an audit of childhood photos of both parents is frequently useful. A DNA test for mutation analysis can be completed on blood, chorionic villi, and amniotic liquid examples. Herewith additionally, preimplantation genetic diagnosis turns into a possibility.

Treatments

The treatment of Noonan disorder is coordinated toward the particular complexities that are apparent in every person. Treatment may require the organized effort of a team of specialists. Pediatricians, doctors who analyze and treat heart abnormalities (cardiologists), doctors who analyze and treat the disorder of the blood and blood-forming tissues (hematologists), doctors who analyze and treat disorders of growth (endocrinologists), as well as other health care experts, may need to efficiently and thoroughly plan and influenced child’s treatment. In certain individuals with congenital heart defects, treatment with specific prescriptions, surgical intervention, and additionally, different procedures might be essential. In such cases, any surgeries performed will depend on the location, seriousness, as well as a combination of anatomical variations from the norm and their related symptoms. Cardiovascular, arteriovenous, as well as lymphatic malformation that might be available must be taken into consideration during choices concerning surgeries. For instance, during a specific type of medical procedure performed on lymphangiomas, there is an expanded hazard that chyle may escape from the largest lymph channel in the body (thoracic duct) into the cavity between the neck and the stomach (thoracic cavity), possibly causing dangerous complications (chylothorax) [6].

For the individuals who likewise have thrombocytopenia, platelet dysfunctions, and additionally coagulation factor insufficiencies, doctors, dental specialists, as well as other health care workers may suggest specific preventive measures previously or take certain steady measures during surgery to counteract, bring down the danger of, or control unusual bleeding.

Respiratory infections ought to be dealt with immediately and energetically. On account of the conceivably expanded danger of bacterial disease of the coating of the heart (endocarditis) and the heart valves, affected people with certain heart deformities might be given prescription before any surgeries, including dental strategies, for example, tooth extractions.

In affected males with cryptorchidism, the medical procedure ought to be performed to move undescended testicles into the scrotum and append them in a fixed position (orchiopexy). Such medical procedure is usually performed somewhere in the range of 1 and 2 years of age to help prevent the danger of related barrenness.

In addition, more suitable supportive measures might be utilized in affected people with lymphedema. 

Early intervention might be significant in assisting children with Noonan syndrome arrive at their potential. Different administrations that might be valuable to affected children may incorporate excellent therapeutic training, language training, non-intrusive treatment, and other medicinal, social, as well as professional administrations. The short stature in patients with Noonan disorder can be treated with a development hormone that has been appeared to improve last adult height.

Hereditary advising is suggested for affected people and their families. As referenced before, intensive clinical assessments might be significant in relatives of analyzed people to distinguish any manifestations and physical qualities that might be related to Noonan syndrome. Another treatment for the confusion is symptomatic and supportive.

Prognosis

New medical problems are not expected to show up in adulthood. Notwithstanding, males who were brought into the world with undescended testicles may have fertility problems. There is no proof for gynecological or childbearing complications in females with Noonan syndrome. A few patients have health problems as an outcome of their inherent heart defect, lymphatic vessel dysplasia, urinary tract malformation, hematological disorder, or other anomaly related to Noonan syndrome. In any case, most adults with Noonan syndrome do not require unique medical considerations.

Other Related Disorders

Side effects of the accompanying issue might be like those of Noonan syndrome. Examinations might be helpful for a differential diagnosis: Cardiofaciocutaneous (CFC) syndrome, an amazingly different hereditary issue, is described by a particular facial appearance like that found in children with Noonan syndrome. Other essential qualities may incorporate uncommonly inadequate, fragile, wavy hair, skin anomalies, heart deformities that are available during childbirth (congenital heart defects), development delays, and moderate to extreme intellectual disability. The individual with cardiofaciocutaneous syndrome ordinarily has a surprisingly enormous head (macrocephaly), an unmistakable brow, and irregular narrowing of the two sides of the forehead (bitemporal tightening); a short, improved nose with a discouraged nasal root; eye discoveries including downwardly inclining eyelids (palpebral fissures), generally divided eyes (visual hypertelorism), or potentially hanging of the upper eyelids (ptosis). In many patients, congenital heart defects are likewise present, especially deterrent of the typical progression of blood from the ventricle of the heart to the lungs (pneumonic valve stenosis) and additionally an unusual opening in the fibrous partition (septum) that partitions the two upper chambers (atria) of the heart (atrial septal imperfections). Heart muscle thickening, otherwise known as hypertrophic cardiomyopathy, can likewise be found. In addition, most people with the disorder experience development delays, moderate to severe intellectual disability, and occasional delays in the procurement of aptitudes requiring the coordination of mental and robust action (psychomotor retardation). Cardiofaciocutaneous syndrome is caused by changes in a few genes: BRAF, MEK1 and 2, and KRAS [7].

Turner syndrome, a numerical disorder of chromosome, has a few similitudes to Noonan syndrome. Actually, in light of the fact that a few people with Noonan syndrome may externally look like those with Turner syndrome (because of specific discoveries that might be related to the two disorders, for example, short stature, webbed neck, and so on.). In the past, NS was referred to as “male Turner syndrome,” “female pseudo-Turner syndrome,” or “Turner phenotype with typical chromosomes.” Nonetheless, there are numerous significant contrasts between the two disorders. Noonan disorder affects the two males and females, and there is a typical chromosomal makeup (karyotype). Just females are affected by Turner syndrome, which is portrayed by variations from the X-chromosome.

Turner syndrome patients have short stature and webbed neck with a low back hairline; short stature; drooping of the upper eyelids (ptosis) as well as generally divided eyes (ocular hypertelorism); broadly separated, altered, as well as immature (hypoplastic) areolas; inherent heart abandons, particularly coarctation; as well as kidney variations from the normal. In practically all cases, juvenile (streak) ovaries are available that cannot deliver the female hormone estrogen. Thus, common optional sexual attributes, for example, the presence of pubic hair, breast development, and menstruation (essential amenorrhea), neglect to create during pubescence. Practically all affected females are infertile. Although intellectual capacities are typically ordinary, a few people may experience difficulties with visualspatial relations (e.g., right-left disorientation). (For more data on Turner syndrome, it would be ideal if you choose “Turner” as your inquiry term in the Rare Disease Database.)

Costello syndrome is an uncommon hereditary disorder described by development delay after birth (postnatal), prompting short stature; a particular facial appearance; excessive, free skin on the neck, palms of the hands, fingers, and bottoms of the feet; development of benign (non-carcinogenic) growths (papillomata) around the mouth (perioral), nostrils (nares) and anus; and gentle to direct intelligent incapacity. Abnormal accumulation of lymph fluid in tissues all through the body (generalized lymphedema) and high birth weight is seen in newborns with the disorder. Likewise, affected newborn children frequently have extremely encouraging and swallowing challenges and may neglect to grow and gain weight at the standard rate (failure to thrive).

Characteristic craniofacial variations from the normal related with the disorder may incorporate an unusually large head (macrocephaly) and broad forehead; a vast, depressed nasal root; strangely wide nostrils; skin folds (epicanthal folds) that may cover the eyes’ inner corners; low-set ears with enormous, thick lobes; as well as unusually thick lips. Other physical highlights may incorporate the development of dry, solidified, thickened skin on the palms and the bottoms of the feet (palmoplantar hyperkeratosis) as well as abnormally profound wrinkles on the palms and soles. Many affected people may likewise have congenital heart defects like those found in Noonan and CFC syndromes. Increasingly particular is the nearness of abnormal and chaotic rhythms in about a third. Most instances of Costello syndrome happen sporadically, with no family history of the disorder, and are brought about by mutations in HRAS. (For more data on this disorder, choose “Costello” as your search term in the Rare Disease Database.)

Numerous giant cell injuries are anomalous pimples (sores), including specific huge cells (giant cells) within the bone and delicate tissue of the jaw. They are found in Noonan syndrome and other covering disorders, for example, CFC syndrome, and are generally diagnosed in the first two decades.

Neurofibromatosis-Noonan syndrome is characterized by the event of neurofibromatosis type I in a relationship with sure signs of Noonan syndrome. Related manifestations and findings may incorporate numerous benign tumors of the nerves and skin, short stature, webbing of the neck (pterygium coli), muscle shortcoming, as well as learning disabilities. Affected people may likewise have individual craniofacial variations from the standard related to Noonan syndrome, including drooping of the upper eyelids (ptosis), low-set ears, and additionally prominent folds between the nose and the lips (nasolabial folds). Moreover, congenital heart defects frequently observed in Noonan syndrome might be available, for example, impediment of the ordinary outflow of blood from the lower right chamber (ventricle) of the heart (pneumonic stenosis) as well as an unusual opening in the fibrous partition (septum) between the upper chambers (atria) of the heart (atrial septal deformity). Neurofibromatosis-Noonan syndrome can be because of the possible event of both disorder in similar people, can be a phenotype of neurofibromatosis type I, or can be a separate disease entity brought about by changes in the NF1 gene but without a some of the characteristic highlights of NF1 [8].

Noonan syndrome with multiple lentigines (NSML, once in the past known as LEOPARD syndrome) is an uncommon acquired disorder portrayed by variations of abnormalities of the skin, the structure and capacity of the heart functions, the inner ear, the head, and facial (craniofacial) region, as well as the genitals. In people with the disorder, the range and seriousness of side effects and physical characteristics may shift from individual to individual. The absolute most basic highlights incorporate lentigines (multiple dark or dull darker spots on the skin); electrocardiographic conduction defects (anomalies of the electrical activity and the coordination of appropriate compressions of the heart); hypertrophic cardiomyopathy, ocular hypertelorism (generally divided eyes); respiratory stenosis (obstruction of the typical outflow of blood from the correct ventricle of the heart); abnormalities of the genitals (in young men normally undescended testicles (cryptorchidism); slowed back growth bringing about short stature, postponed development; and deafness or hearing malfunction because of the breakdown of the internal ear (sensorineural deafness). NSML is an autosomal dominant hereditary disorder brought about by a mutation in one of two genes: PTPN11 or RAF1 [9].

Epidemiology

The incidence of Noonan syndrome is projected to be between 1:1000 and 1:2500 live births. The frequency of Noonan syndrome seems to be steady around worldwide. The essential source of morbidity and mortality in patients with Noonan syndrome depends upon the presence and kind of congenital coronary diseases. Noonan syndrome is additionally described by a slight increase in the risk of the specific syndrome. In a writing review spanning 1937-2010, Kratz et al. found the most normally detailed malignant growths in Noonan syndrome, as analyzed in a total of 1051 patients, to be neuroblastoma (8 cases), lowgrade glioma (6 cases), acute lymphoblastic leukemia (8 cases) and rhabdomyosarcoma (6 cases); like Noonan syndrome, these diseases are related with RAS cell signaling pathway mutation. Juvenile myelomonocytic leukemia and myeloproliferative disorder have likewise been related to Noonan disorder.

An independent study showed that the nourishing problem contributes to development weakness during the first year of life in children with Noonan syndrome [10]. Despite the fact that PTPN11 mutation, more prominent gestational age, and heart surgery likewise negatively affected weight increase and length in the examination, the specialists found that at age one year, children with feeding issue weighed, all things considered, 290 g less than children without feeding issues and were, by an average, 0.8 cm shorter.

A study likewise exhibited a raised cancer in patients with Noonan syndrome [11]. Twelve of 297 patients with a PTPN11 mutation built up a malignancy - a 3.5-fold increased risk compared with that of healthy people. Hematologic malignancies happened most frequently, while two malignancies not recently observed in Noonan syndrome were discovered: a mastocytosis and malignant epithelioid angiosarcoma. A study by Cessans et al. comparing development patterns in patients and Noonan syndrome dependent on genotype found that during childbirth, patients with PTPN11 mutation would, in general, be shorter and thinner than were those with mutations in SOS1, KRAS, or Noonan syndrome with various lentigines–related PTPN11 (NSML-PTPN11). Also, at age two years, development retardation was increasingly severe and frequent in patients with PTPN11 mutations than in those with mutations in SOS1 or NSMLPTPN11. At age ten years, although the fact that patients with Noonan syndrome had lower body mass records all in general, no development differences were found between the various genotypes.

The confusion is available from birth; however, age impacts facial phenotype. Newborn children with Noonan syndrome can be hard to recognize by facial appearance alone. The phenotype turns out to be all the more striking in early adolescence, however, with advancing age, and it might again become to be very inconspicuous. Careful assessment of an influenced child’s parents may, in truth, uncover that they are somewhat affected. Noonan disorder happens in either a sporadic or autosomal prevailing design. In either case, males and females are similarly influenced. Noonan disorder is pan-ethnic as per race.

1. Hasle H. Malignant diseases in Noonan syndrome and related disorders. Horm Res. 2009; 72: 8-14.

2. van der Burgt I. Noonan syndrome. Orphanet J Rare Dis. 2007; 2: 4.

3. Miller BS. The History of Noonan Syndrome. Pediatr Endocrinol Rev. 2019; 16: 424-427.

4. Renée L Roelofs, Nikki Janssen, Ellen Wingbermühle, Roy P C Kessels, Jos I M Egger, et al. Intellectual development in Noonan syndrome: a longitudinal study. Brain Behav. 2016; 6: e00479.

5. Vikas Bhambhani, Maximilian Muenke. Noonan syndrome. Am Fam Physician. 2014; 89: 37-43.

6. Amy E Roberts, Judith E Allanson, Marco Tartaglia, Bruce D Gelb. Noonan syndrome. Lancet. 2013; 381: 333-42.

7. Alireza Tafazoli, Peyman Eshraghi, Zahra Kamel Koleti, Mohammadreza Abbaszadegan. Noonan syndrome - a new survey. Arch Med Sci. 2017; 13: 215-222.

8. Christos Yapijakis, Nikos Pachis, Costas Voumvourakis. Neurofibromatosis-Noonan Syndrome: A Possible Paradigm of the Combination of Genetic and Epigenetic Factors. Adv Exp Med Biol. 2017; 987: 151-159.

9. Marco Tartaglia, Bruce D Gelb, Martin Zenker. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011; 25: 161-79.

10. E A Croonen, W Nillesen, C Schrander, M Jongmans, H Scheffer, C Noordam, et al. Noonan syndrome: comparing mutation-positive with mutation-negative dutch patients. Mol Syndromol. 2013; 4: 227-34.

11. Marjolijn C J Jongmans, Ineke van der Burgt, Peter M Hoogerbrugge, Kees Noordam, Helger G Yntema, Willy M Nillesen, et al. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet. 2011; 19: 870-4.